Federal Register of Legislation - Australian Government

Primary content

PB 137 of 2021 Arrangements as made
This instrument amends the National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020 to extend it for a further three months until 1 April 2022.
Administered by: Health and Aged Care
Registered 21 Dec 2021
Tabling HistoryDate
Tabled HR08-Feb-2022
Tabled Senate08-Feb-2022
Date of repeal 08 Sep 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 137 of 2021

 

National Health (COVID-19 Supply of Pharmaceutical Benefits) Amendment (Additional Extension) Special Arrangement 2021

I, Elizabeth Flynn, delegate of the Minister for Health and Aged Care, make the following special arrangement under subsection 100(2) of the National Health Act 1953.

Dated   17 December 2021                             

Elizabeth Flynn

Acting First Assistant Secretary

Technology Assessment and Access Division

Department of Health

 

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020       2

 

 


1  Name

(1)      This instrument is the National Health (COVID-19 Supply of Pharmaceutical Benefits) Amendment (Additional Extension) Special Arrangement 2021.

(2)    This instrument may also be cited as PB 137 of 2021.

 

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

On the day after this instrument is registered

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 100(2) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

National Health (COVID-19 Supply of Pharmaceutical Benefits) Special Arrangement 2020

1  Section 4

Omit “1 January 2022”, substitute “1 April 2022”.

2  Subsection 6(1) (definition of phone attendance)

Omit “Health Insurance (Section 3C General Medical Services – COVID-19 Telehealth and Telephone Attendances) Determination 2020”, substitute “Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Determination 2021”.

3  Subsection 6(1) (definition of telehealth attendance)

Omit “Health Insurance (Section 3C General Medical Services – COVID-19 Telehealth and Telephone Attendances) Determination 2020”, substitute “Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Determination 2021”.

4  Subsection 6(2)

Omit “Health Insurance (Section 3C General Medical Services – COVID-19 Telehealth and Telephone Attendances) Determination 2020”, substitute “Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Determination 2021”.

5  Paragraph 9(1)(c)

Omit “Health Insurance (Section 3C General Medical Services – COVID-19 Telehealth and Telephone Attendances) Determination 2020”, substitute “Health Insurance (Section 3C General Medical Services – Telehealth and Telephone Attendances) Determination 2021”.

6  After Section 17

Insert:

17A  Continued application of Special Arrangement as in force before commencement of the National Health (COVID‑19 Supply of Pharmaceutical Benefits) Amendment (Additional Extension) Special Arrangement 2021

(1)  This Special Arrangement, as in force immediately before the commencement of this section, continues to apply on and after that commencement in relation to the supply of a pharmaceutical benefit made under this Special Arrangement before that commencement.

7  Subsection 18(1)

Omit “1 January 2022”, substitute “1 April 2022”.